featured news
Optimi Health to Provide MDMA for Alcohol Addiction Research in Israel
Cybin Raises $150 Million Via Oversubscribed Private Placement
Gilgamesh Receives $14 Million NIDA Grant to Develop Ibogaine Analog for Addiction Treatment
Ketamine: Addiction Treatment or Enabler?
